New & Notable
Click Therapeutics gains $50M, commercialization rights for schizophrenia PDT
Boehringer Ingelheim is giving Click Therapeutics the commercialization and marketing rights for a prescription digital therapeutic to treat some of the negative effects of schizophrenia.
Mega-deals drive Q1 digital health funding to $4B
Over half of Q1 funding was concentrated in 12 mega-deals, including Whoop, Talkiatry and OpenEvidence, each of which raised over $200 million in recent fundraising rounds.
Wearables maker Whoops snags $575M at $10B valuation
The eye-popping figure will enable the company to support its global expansion and scale its fitness tracker amid the loosening regulations around healthcare wearables.
Will ACCESS move the needle on tech-enabled chronic care?
Though digital health leaders view CMS' ACCESS model as a promising pathway to value-based payment, gaps remain that could slow adoption and make the model unsustainable.
UHS to acquire Talkspace for $835M as hospital operator pursues behavioral health growth
— Healthcare DiveHealthcare Strategies: A Podcast
-
A podcast for healthcare professionals seeking solutions to today's and tomorrow's top challenges. Hosted by the editors of Xtelligent Healthcare Media, this podcast series focuses on real-world use cases that are leading to tangible improvements in care quality, outcomes, and cost.
Guests from leading provider, payer, government, and other organizations share their approaches to transforming healthcare in a meaningful and lasting way.
View All Episodes
Latest News
-
Omada Health reports Q4 profit, offers new GLP-1 cash-pay option
The digital health provider reported a profitable fourth quarter with strong revenue and membership growth in 2025, and a new employer-focused cash-pay option for GLP-1s.
-
Study: Medicare patients turn to telehealth for chronic care
Research shows that the use of telehealth for non-mental healthcare, particularly chronic conditions, is comparable to mental healthcare visits among Medicare patients.
-
Hims & Hers continues global expansion with $1.15B acquisition
Hims & Hers is acquiring Eucalyptus, which operates digital health clinics in Australia, Japan and Europe, giving the U.S. telehealth company access to new markets.
-
Apple Watch could miss hypertension diagnoses in seniors
Research suggests there are gaps in the smartwatch's ability to detect undiagnosed hypertension, particularly among older adults who experience higher rates of the condition.
-
Talkiatry snags $210M to expand telepsychiatry care
The telepsychiatry provider has doubled its total funding with this latest financing round, suggesting continued interest in telehealth-enabled behavioral health services.
-
Telehealth, hospital-at-home waivers get years-long extensions
Telehealth flexibilities and the federal hospital-at-home waiver received two-and five-year extensions, respectively, after the House passed the 2026 funding package.
Features
-
Why Walmart's return to telehealth features a marketplace model
Earlier this year, Walmart launched a new virtual care service with marked differences from its initial foray, indicating a new approach for non-traditional healthcare players.
-
Looser FDA rules for wearables may add to provider burdens
The FDA's decision to limit the regulation of certain general wellness wearables could leave clinicians to manage low-quality data risks, including patient anxiety and inaccurate readings.
-
Differentiation, profitability prospects key to digital health market success
Factors like differentiation, integration, evaluation and solid pathways to profitability will make or break digital health companies in the coming year, experts predict.
-
6 trends driving digital health market stabilization, growth
In 2026, experts expect consolidation, AI integration and an emphasis on ROI to drive stabilization, and potentially growth, in the digital health market.